首页|期刊导航|Virologica Sinica|Efficacy and safety of switching from lopinavir/ritonavir-based regimens to bictegravir/emtricitabine/tenofovir alafenamide in people living with HIV:A multicenter retrospective study
Efficacy and safety of switching from lopinavir/ritonavir-based regimens to bictegravir/emtricitabine/tenofovir alafenamide in people living with HIV:A multicenter retrospective study
Jiantao Fu Yifan Guo Guoxiang Zheng Zongxing Yang Jinchuan Shi Dingyan Yan Jianhua Yu Lijun Sun Hongxin Zhao
Virologica Sinica2025,Vol.40Issue(5):P.835-841,7.
Virologica Sinica2025,Vol.40Issue(5):P.835-841,7.DOI:10.1016/j.virs.2025.10.003
Efficacy and safety of switching from lopinavir/ritonavir-based regimens to bictegravir/emtricitabine/tenofovir alafenamide in people living with HIV:A multicenter retrospective study
摘要
关键词
Human immunodeficiency virus(HIV)/Virological suppression/LPV/r/BIC/FTC/TAF/Metabolic outcomes分类
医药卫生引用本文复制引用
Jiantao Fu,Yifan Guo,Guoxiang Zheng,Zongxing Yang,Jinchuan Shi,Dingyan Yan,Jianhua Yu,Lijun Sun,Hongxin Zhao..Efficacy and safety of switching from lopinavir/ritonavir-based regimens to bictegravir/emtricitabine/tenofovir alafenamide in people living with HIV:A multicenter retrospective study[J].Virologica Sinica,2025,40(5):P.835-841,7.基金项目
supported by the Capital''s Funds for Health Improvement and Research(CFH2024-2-2175). (CFH2024-2-2175)